Clinical Study

Neurostar Transcranial Magnetic Stimulation (Tms) Therapy Study In Depressed Adolescents

Posted Date: Oct 6, 2017

  • Investigator: Jeffrey Strawn
  • Co-Investigator: Sireesha Pothukuchi
  • Specialties: Depression, Adolescent Psychiatry/Psychology, Psychiatry/Psychology
  • Type of Study: Device

The purpose of this study is to get information about using TMS as a treatment for depression in adolescents with Major Depressive Disorder (MDD) who have not had a good response to medication to treat their depression. The NeuroStar has been approved by


- Patients 12-21 Years Old - Resistance To Prior Antidepressant Medication - Depression Illness Lasting Greater Than 4 Weeks And Less Than 3 Years


Adolescents, Depression, Psychiatry, Transcranial Magnetic Stimulation (Tms) Therapy, Null

For More Information:

Sara Varney
(513) 558-2931

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.